Repligen Corporation to Present at Upcoming March Conferences

Core Viewpoint - Repligen Corporation is actively participating in three upcoming investor conferences, highlighting its commitment to engaging with investors and stakeholders in the bioprocessing technology sector [1][4]. Company Overview - Repligen Corporation is a global life sciences company that specializes in developing and commercializing innovative bioprocessing technologies and systems aimed at enhancing the efficiency of biological drug manufacturing [3]. - The company serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide, focusing on areas such as Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins [3]. - Repligen's corporate headquarters is located in Waltham, Massachusetts, with manufacturing sites primarily in the U.S. and additional key locations in Estonia, France, Germany, Ireland, the Netherlands, and Sweden [3]. Upcoming Conferences - Repligen will participate in the Leerink Global Healthcare Conference from March 8 to 11, 2026, with CFO Jason Garland scheduled for an analyst-led discussion on March 10 at 11:20 a.m. ET [4]. - The company will also attend the Barclays 28th Annual Global Healthcare Conference from March 10 to 12, 2026, where Jason Garland will speak on March 11 at 10:30 a.m. ET [4]. - Additionally, Repligen will be part of the 2026 KeyBanc Virtual Healthcare Forum on March 17 and 18, 2026, featuring CEO Olivier Loeillot in an analyst-led discussion on March 18 at 2:15 p.m. ET [4].